Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. NVS
NVS logo

NVS

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

NVS News

BioArctic AB Reports Strong Earnings, Positive Outlook for Leqembi Sales

May 20 2026Yahoo Finance

Analysis of Trends in International Stock ETF Investments

May 19 2026Fool

Novo Nordisk Goes All In on Wegovy Global Launch

May 18 2026CNBC

Novartis to Close Wehr Facility by End of 2028

May 06 2026NASDAQ.COM

German Stock Market Hit Hard by New COVID Variant Concerns

May 01 2026CNBC

Latest Developments in the Biotech Sector

Apr 30 2026NASDAQ.COM

Market Volatility Amidst Surging Oil Prices

Apr 30 2026CNBC

AstraZeneca and GSK Q1 Earnings Beat Expectations

Apr 29 2026CNBC

UAE's OPEC Exit Sends Shockwaves Through Markets

Apr 29 2026CNBC

Novartis Reports Weaker-Than-Expected Q1 Results Amid Generic Competition

Apr 28 2026seekingalpha

Novartis Projects 8% Sales Growth for 2025 Amid Patent Challenges

Apr 28 2026seekingalpha

Novartis CEO Warns of Drug Pricing Policy Impact

Apr 28 2026CNBC

Novartis CEO Warns of U.S. Drug Pricing Policy Impact

Apr 28 2026Newsfilter

BYD Faces EU Scrutiny Over Labor Abuse Allegations at Hungary Factory

Apr 28 2026CNBC

Novartis Q1 Core EPS Declines 15%, Missing Consensus

Apr 28 2026seekingalpha

European Stocks Expected to Open Higher Amid Iran Proposal and Earnings Reports

Apr 28 2026CNBC